Zhang S, Li S, Liu J, Yang C, et al. Comparative Efficacy and Safety of TKIs Alone or in Combination With Antiangiogenic Agents in Advanced EGFR-Mutated NSCLC as the First-Line Treatment: A Systematic Review and Meta-Analysis. Clin Lung Cancer 2022;23:159-169.
PMID: 34247986